Lackmann M - Search Results

1

The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2.

Stacker SA, Runting AS, Caesar C, Vitali A, Lackmann M, Chang J, Ward L, Wilks AF. Stacker SA, et al. Among authors: lackmann m. Growth Factors. 2000;18(3):177-91. doi: 10.3109/08977190009003243. Growth Factors. 2000. PMID: 11334054

2

Biomolecular interaction analysis of IFN gamma-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexes.

Lackmann M, Harpur AG, Oates AC, Mann RJ, Gabriel A, Meutermans W, Alewood PF, Kerr IM, Stark GR, Wilks AF. Lackmann M, et al. Growth Factors. 1998;16(1):39-51. doi: 10.3109/08977199809017490. Growth Factors. 1998. PMID: 9777369

3

Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approach.

Lackmann M, Bucci T, Mann RJ, Kravets LA, Viney E, Smith F, Moritz RL, Carter W, Simpson RJ, Nicola NA, Mackwell K, Nice EC, Wilks AF, Boyd AW. Lackmann M, et al. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2523-7. doi: 10.1073/pnas.93.6.2523. Proc Natl Acad Sci U S A. 1996. PMID: 8637907 Free PMC article.

4

Vascular remodeling in cancer.

Farnsworth RH, Lackmann M, Achen MG, Stacker SA. Farnsworth RH, et al. Among authors: lackmann m. Oncogene. 2014 Jul 3;33(27):3496-505. doi: 10.1038/onc.2013.304. Epub 2013 Aug 5. Oncogene. 2014. PMID: 23912450 Review.

5

Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization.

Lackmann M, Oates AC, Dottori M, Smith FM, Do C, Power M, Kravets L, Boyd AW. Lackmann M, et al. J Biol Chem. 1998 Aug 7;273(32):20228-37. doi: 10.1074/jbc.273.32.20228. J Biol Chem. 1998. PMID: 9685371 Free article.

6

Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.

Lawrenson ID, Wimmer-Kleikamp SH, Lock P, Schoenwaelder SM, Down M, Boyd AW, Alewood PF, Lackmann M. Lawrenson ID, et al. Among authors: lackmann m. J Cell Sci. 2002 Mar 1;115(Pt 5):1059-72. doi: 10.1242/jcs.115.5.1059. J Cell Sci. 2002. PMID: 11870224

7

"Eph receptor signalling; dimerisation just isn't enough".

Vearing CJ, Lackmann M. Vearing CJ, et al. Among authors: lackmann m. Growth Factors. 2005 Mar;23(1):67-76. doi: 10.1080/08977190500055869. Growth Factors. 2005. PMID: 16019428 Review. No abstract available.

8

Signals from Eph and ephrin proteins: a developmental tool kit.

Boyd AW, Lackmann M. Boyd AW, et al. Among authors: lackmann m. Sci STKE. 2001 Dec 11;2001(112):re20. doi: 10.1126/stke.2001.112.re20. Sci STKE. 2001. PMID: 11741094 Review.

9

Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.

Vail ME, Murone C, Tan A, Hii L, Abebe D, Janes PW, Lee FT, Baer M, Palath V, Bebbington C, Yarranton G, Llerena C, Garic S, Abramson D, Cartwright G, Scott AM, Lackmann M. Vail ME, et al. Among authors: lackmann m. Cancer Res. 2014 Aug 15;74(16):4470-81. doi: 10.1158/0008-5472.CAN-14-0218. Cancer Res. 2014. PMID: 25125683

10

EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

Day BW, Stringer BW, Al-Ejeh F, Ting MJ, Wilson J, Ensbey KS, Jamieson PR, Bruce ZC, Lim YC, Offenhäuser C, Charmsaz S, Cooper LT, Ellacott JK, Harding A, Leveque L, Inglis P, Allan S, Walker DG, Lackmann M, Osborne G, Khanna KK, Reynolds BA, Lickliter JD, Boyd AW. Day BW, et al. Among authors: lackmann m. Cancer Cell. 2013 Feb 11;23(2):238-48. doi: 10.1016/j.ccr.2013.01.007. Cancer Cell. 2013. PMID: 23410976 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters